Attached files

file filename
10-Q - PLATA RESOURCES INC. FORM 10-Q MARCH 31, 2011 - NEXUS BIOPHARMA INCbody_plata10qmar312011.htm
EX-32.1 - CERTIFICATE 18 U.S.C. SECT 1350 D. CALISO, CEO - NEXUS BIOPHARMA INCcertsect906dcalisoceo.htm
EX-31.1 - CERTIFICATE RULE 13A-14A DEXTER CALISO, CEO - NEXUS BIOPHARMA INCcertrule13a14adcalisoceo.htm
EX-31.2 - CERTIFICATE RULE 13A-14A P. CORANES, CFO - NEXUS BIOPHARMA INCcertrule13a14apcoranescfo.htm

Exhibit 32.2


CERTIFICATE PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report (the “Report”) on the Form 10-Q of Plata Resources, Inc. (the “Company”) for the three months ended March 31, 2011, as filed with the Securities and Exchange Commission on the date hereof, I, Presentacion A. Coranes, Chief Accounting Officer, Chief Financial Officer and Director, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

1. The Quarterly Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities and Exchange Act of 1934, as amended; and

2. The information contained in this Quarterly Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

Dated: April 25, 2011

PRESENTACTION A. CORANES                                                                
Presentacion A. Coranes
Chief Accounting Officer
Chief Financial Officer and Director



 
-1-